Collaboration leverages Converge Bio's proprietary generative AI to design and optimize novel tri-specific antibodies for ...
Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics ...
OnKure Therapeutics Inc. (Nasdaq: OKUR), a Boulder precision-oncology company that went public in 2024 via a merger with California-based Reneo Pharmaceuticals Inc., expects to raise about $150 ...
In today's Readout newsletter, how China's biotech boom is rewriting everything and how an NIH crackdown is disrupting global ...
DifGen Pharmaceuticals and Aveva Drug Delivery Systems today announced a strategic platform collaboration with Biostax Corp d/b/a Attune Biotech, SGP Holdings, and Callan JMB to lead U.S.-based ...
The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...
BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced it has been named “Overall Immunology Company of the Year” in the fifth annual BioTech ...
China's emergence as a second hub of pharmaceutical innovation could trigger massive changes to the global drug market, ...
Insmed said Monday that the addition of its drug Arikayce to a standard treatment for patients with a rare bacterial lung ...
The company discontinued developing emugrobart after two studies showed the drug didn’t achieve intended outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results